Home LiteratureArticle Details
PMID: 3297887 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Reversal of insulin resistance in diabetic rat adipocytes by insulin therapy. Restoration of pool of glucose transporters and enhancement of glucose-transport activity.

Diabetes ·Vol. 36 ·No. 8 ·1987-08-00 ·Pages 925-31

Karnieli E, Armoni M, Cohen P, Kanter Y, Rafaeloff R

Abstract

To determine the role of insulin in reversing the insulin resistance associated with depletion of the intracellular pool of glucose transporters, streptozocin-induced diabetic rats were treated with 5 U/day s.c. of insulin for 0, 8, or 14 days. At each time point, adipose cells were isolated, and 3-O-methylglucose transport was measured in the absence and presence of 1000 microU/ml insulin. With the cytochalasin B-binding assay, concentrations of glucose transporters in the plasma and the low-density microsomal membrane fractions were determined. Eight-day insulin therapy enhanced glucose transport rate (mean +/- SE) from 0.2 +/- 0.0 to 1.1 +/- 0.1 fmol X cell-1 X min-1 in the basal state and from 0.8 +/- 0.1 to 5.5 +/- 0.4 fmol X cell-1 X min-1 in the insulin-stimulated state in untreated and treated diabetic rats, respectively; this is a 3-fold increment of glucose transport rate in both states compared with control rats. After 14-day insulin therapy, glucose-transport activity declined toward normal but still remained approximately 1.5- and 4-fold higher than control and diabetic rats, respectively. Despite the persistent enhancement of glucose transport rate, concentration of glucose transporters in the intracellular pool was restored only to its prediabetic state. Likewise, the increased concentration of glucose transporters in the plasma membranes after insulin stimulation was similar to that of control rats. Thus, we suggest that 8-14 days of insulin therapy reversed the insulin resistance in diabetic rat adipocytes by at least two mechanisms: restoration of the intracellular pool of glucose transporters and enhancement of glucose-transport activity.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
3-O-Methylglucose Adipose Tissue/drug effects,metabolism Animals Binding Sites Cytochalasin B/metabolism Diabetes Mellitus, Experimental/drug therapy,metabolism Insulin/therapeutic use Insulin Resistance Male Methylglucosides/metabolism Monosaccharide Transport Proteins/metabolism Rats Rats, Inbred Strains Subcellular Fractions/drug effects,metabolism
Chemicals
Insulin Methylglucosides Monosaccharide Transport Proteins 3-O-Methylglucose Cytochalasin B
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Karnieli E
Armoni M
Cohen P
Kanter Y
Rafaeloff R
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
0012-1797
Published
1987-08-00
Pages
925-31
Language
English
Region
United States
NLM ID
0372763
Subset
IM
Grants
NIADDK NIH HHS · AM-31489 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com